In pharmacoresistant epilepsy, CCR2 is highly expressed in neurons and monocytes suggesting that CCL2 and its receptor may play a role in epileptogenesis (Bozzi and Caleo, 2016; Varvel et al., 2016). The gene discussed is CCL2; the disease is epilepsy.